Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Silk Road Medical, Inc SILK
$36.73
-$0.19 (-0.51%)
На 18:01, 12 мая 2023
+21.15%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
1430966345.00000000
-
week52high
58.04
-
week52low
27.30
-
Revenue
138638000
-
P/E TTM
-27
-
Beta
1.16559600
-
EPS
-1.55000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Citigroup | Sell | Neutral | 11 июл 2022 г. |
| Citigroup | Neutral | Neutral | 17 мая 2022 г. |
| Wolfe Research | Outperform | 06 апр 2022 г. | |
| Piper Sandler | Neutral | Neutral | 04 апр 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Davis Andrew S. | D | 54865 | 6753 | 01 февр 2023 г. |
| Davis Andrew S. | D | 98205 | 6753 | 01 февр 2023 г. |
| Davis Andrew S. | A | 104958 | 6753 | 01 февр 2023 г. |
| Chou Tony M. | D | 75707 | 13008 | 01 февр 2023 г. |
| Buchanan Lucas W. | D | 7331 | 25762 | 19 янв 2023 г. |
| Buchanan Lucas W. | D | 7643 | 12766 | 19 янв 2023 г. |
| Buchanan Lucas W. | D | 188811 | 2716 | 19 янв 2023 г. |
| Buchanan Lucas W. | D | 191527 | 25762 | 19 янв 2023 г. |
| Buchanan Lucas W. | A | 217289 | 25762 | 19 янв 2023 г. |
| Buchanan Lucas W. | A | 204293 | 12766 | 19 янв 2023 г. |
Новостная лента
Silk Road Medical (SILK) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 19:52
Silk Road Medical (SILK) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.48 per share a year ago.
Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders
GlobeNewsWire
04 мая 2023 г. в 16:30
SUNNYVALE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the company will host an investor education webcast at 11:00 a.m. Eastern Time on Thursday, May 25, 2023. The event represents the first in a series of webcasts being organized by the company to educate investors on TCAR and the treatment of carotid artery disease.
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
GlobeNewsWire
26 апр 2023 г. в 16:30
SUNNYVALE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2023 Healthcare Conference.
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
GlobeNewsWire
18 апр 2023 г. в 16:30
SUNNYVALE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Silk Road Medical: Today Best Nearby Cap-Gain Medical Equipment Stock Prospect
Seeking Alpha
05 мар 2023 г. в 10:45
“A 3-5 month prospect from here of SILK share prices could reasonably range from a $47.07 low to a $61.27 high from its $47.29 present price, a gain of +29.6%." The result of 54 positions like today's in the past 4 years of 874 market days was average net gains at 21.7% each during 51 market days (nearly 3 months).